Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cheng

Showing results (71-80 of 1,814) with videos related to

Pageof 182
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 27, 2026
Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial's Use of Healthcare Systems Data for Clinical Follow-UpK Shu, M Cheng
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|August 24, 1999
Treatment of tennis elbow by acupuncture and moxibustionZ Guo, M Cheng
Dimensions in Health Service|July 1, 1982
Shared biomedical engineering: a cost-benefit analysisM Cheng, J Prud'homme
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2002
Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous coronary interventionJudy W M Cheng
Journal of Cardiovascular Pharmacology and Therapeutics|November 12, 2013
Updates in antiplatelet agents used in cardiovascular diseasesJudy W M Cheng
Clinical Therapeutics|March 18, 2008
Aliskiren: renin inhibitor for hypertension managementJudy W M Cheng
Medical & Biological Engineering & Computing|May 1, 1994
Technical services for healthcare facilities: a model for developing countriesM Frize, M Cheng
The Annals of Pharmacotherapy|September 21, 2006
Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular eventsJudy W M Cheng
Clinical Therapeutics|April 24, 2012
Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromesJudy W M Cheng
Cardiology in Review|December 15, 2004
Tezosentan in the management of decompensated heart failureJudy W M Cheng
Pageof 182

Showing results (71-80 of 1,814) with videos related to

Sort By:
Pageof 182
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 27, 2026
Valuing Public Sector Data Assets: Methodological Perspectives From the Add-Aspirin Trial's Use of Healthcare Systems Data for Clinical Follow-UpK Shu, M Cheng
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|August 24, 1999
Treatment of tennis elbow by acupuncture and moxibustionZ Guo, M Cheng
Dimensions in Health Service|July 1, 1982
Shared biomedical engineering: a cost-benefit analysisM Cheng, J Prud'homme
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2002
Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous coronary interventionJudy W M Cheng
Journal of Cardiovascular Pharmacology and Therapeutics|November 12, 2013
Updates in antiplatelet agents used in cardiovascular diseasesJudy W M Cheng
Clinical Therapeutics|March 18, 2008
Aliskiren: renin inhibitor for hypertension managementJudy W M Cheng
Medical & Biological Engineering & Computing|May 1, 1994
Technical services for healthcare facilities: a model for developing countriesM Frize, M Cheng
The Annals of Pharmacotherapy|September 21, 2006
Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular eventsJudy W M Cheng
Clinical Therapeutics|April 24, 2012
Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromesJudy W M Cheng
Cardiology in Review|December 15, 2004
Tezosentan in the management of decompensated heart failureJudy W M Cheng
Pageof 182